CALIFORNIA — Patients For Affordable Drugs Now launched new ads today urging Reps. Scott Peters (CA-52) and Lou Correa (CA-46) to vote for passage of strong Medicare negotiation legislation in the Build Back Better Act. The campaign includes TV and digital ads featuring patient advocate Kris Garcia, who lives with multiple bleeding disorders including hemophilia. It also includes grassroots advocacy, in which patients will write and call their members of Congress directly asking them to pass the Build Back Better Act, including legislation to lower drug prices for patients.
“Each infusion of medicine that I need to live costs nearly $40,000. But without it, a minor accident can become a medical crisis for me and a financial crisis for my family,” Kris, a father of three based in Denver, explains in the ads. “For millions of Americans like me, this isn’t about politics — this is about life and death.”
In 2019, Rep. Peters (CA-52) touted his support for H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices. But after receiving over $239,000 in contributions from the pharmaceutical and health products industry, he flip-flopped to oppose the bill, even threatening to derail his party’s budget bill if it includes the legislation. Last month, he voted against inclusion of legislation to allow Medicare to negotiate lower drug prices in the Build Back Better Act. Watch the CA-52 ad here.
“Scott Peters is standing with Big Pharma and against the will of voters, opposing a plan to lower drug prices,” the ad in CA-52 says. “Tell Representative Peters to fight for patients and vote for the Build Back Better Act.”
Rep. Correa (CA-46) voted for the drug pricing measure H.R. 3 in 2019. This year, however, Rep. Correa joined Rep. Peters in introducing a rival drug pricing bill that fails to empower negotiation in Medicare Part D, which accounts for 83 percent of Medicare drug spending, excludes most expensive Part B drugs from negotiation, and has a much higher out-of-pocket cap. He also signed a letter led by Rep. Peters voicing concerns about partisan drug pricing reforms in May and enjoys a close relationship with pharma-allied groups opposed to negotiation. Watch the CA-46 ad here.
“Lou Correa has the chance to fight for Californians by letting Medicare negotiate lower drug prices,” the ad in CA-46 says. “Tell Representative Correa to stand with patients against Big Pharma and vote yes on the Build Back Better Act.”
“91 percent of Californians support allowing Medicare to negotiate lower drug prices, and 75 percent of voters think drug prices are unreasonable,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It is imperative that Reps. Peters and Correa seize this moment and deliver on promises to allow Medicare to negotiate lower drug prices for Americans — instead of supporting a weak and ineffective substitute masquerading as negotiation and designed to protect Big Pharma.”
Below are digital ads also running in each district:
P4ADNow also launched ads today urging Reps. Stephanie Murphy (FL-07), Josh Gottheimer (NJ-05), and Kathleen Rice (NY-04) to pass strong Medicare negotiation legislation in the Build Back Better Act. These ads come on the heels of P4ADNow’s Arizona ad launch and are running simultaneously with two nationalads that combat Big Pharma’s lies and scare tactics. These ads are part of a seven-figure campaign that includes digital ads running across a variety of websites and news outlets and congressional outreach, where patient advocates are contacting their members of Congress to demand passage of legislation to allow Medicare to negotiate. P4ADNow’s recent ads can be found here.
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that includes legislation to let Medicare negotiate and has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, which recently advanced out of the Ways and Means Committee.
| ### |
NEW JERSEY — Patients For Affordable Drugs Now launched a new ad today urging Rep. Josh Gottheimer (NJ-05) to vote for passage of strong Medicare negotiation legislation in the Build Back Better Act. The campaign includes TV and digital ads featuring patient advocate Kris Garcia, who lives with multiple bleeding disorders including hemophilia. It also includes grassroots advocacy, in which patients will write and call their members of Congress directly asking them to pass the Build Back Better Act, including legislation to lower drug prices for patients.
“Each infusion of medicine that I need to live costs nearly $40,000. But without it, a minor accident can become a medical crisis for me and a financial crisis for my family,” Kris, a father of three based in Denver, explains in the ad. “For millions of Americans like me, this isn’t about politics — this is about life and death.”
Rep. Gottheimer (NJ-05) voted for a drug pricing measure to allow Medicare to negotiate lower drug prices in 2019 but is now criticizing the Democrats’ efforts to advance an identical bill as part of reconciliation in the House and is defending the drug industry. He also signed onto a rival drug pricing bill this year that fails to empower negotiation in Medicare Part D, which accounts for 83 percent of Medicare drug spending, excludes most expensive Part B drugs from negotiation, and has a much higher out-of-pocket cap.
Watch the NJ-05 ad here.
“Josh Gottheimer has a chance to fight for New Jerseyans by letting Medicare negotiate lower drug prices,” the ad in NJ-05 says. “Tell Representative Gottheimer to stand with patients and vote yes on the Build Back Better Act.”
Below is a digital ad also running in the district:
“90 percent of New Jerseyans in Rep. Gottheimer’s district support allowing Medicare to negotiate lower drug prices, and 79 percent think drug prices are unreasonable,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It is imperative that Rep. Gottheimer seize this moment and deliver on promises to allow Medicare to negotiate lower drug prices for Americans.”
P4ADNow also launched ads today urging Reps. Lou Correa (CA-46), Scott Peters (CA-52), Stephanie Murphy (FL-07), and Kathleen Rice (NY-04) to pass strong Medicare negotiation legislation in the Build Back Better Act. These ads come on the heels of P4ADNow’s Arizona ad launch and are running simultaneously with two nationalads that combat Big Pharma’s lies and scare tactics. These ads are part of a seven-figure campaign that includes digital ads running across a variety of websites and news outlets and congressional outreach, where patient advocates are contacting their members of Congress to demand passage of legislation to allow Medicare to negotiate. P4ADNow’s recent ads can be found here.
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that includes legislation to let Medicare negotiate and has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, which recently advanced out of the Ways and Means Committee.
| ### |
NEW YORK — Patients For Affordable Drugs Now launched a new ad today urging Rep. Kathleen Rice (NY-04) to vote for passage of strong Medicare negotiation legislation in the Build Back Better Act. The campaign includes TV and digital ads featuring patient advocate Kris Garcia, who lives with multiple bleeding disorders including hemophilia. It also includes grassroots advocacy, in which patients will write and call their members of Congress directly asking them to pass the Build Back Better Act, including legislation to lower drug prices for patients.
“Each infusion of medicine that I need to live costs nearly $40,000. But without it, a minor accident can become a medical crisis for me and a financial crisis for my family,” Kris, a father of three based in Denver, explains in the ad. “For millions of Americans like me, this isn’t about politics — this is about life and death.”
Rep. Rice supported H.R. 3 in 2019, and in 2020 campaigned on lowering drug prices and taking on Big Pharma, but broke her promise to patients and flippedher position by voting against including identical legislation in the Build Back Better Act last month in the House Energy and Commerce Committee. She also signed onto a rival drug pricing bill that fails to empower negotiation in Medicare Part D, which accounts for 83 percent of Medicare drug spending, excludes most expensive Part B drugs from negotiation, and has a much higher out-of-pocket cap.
Watch the NY-04 ad here.
“Kathleen Rice has a chance to do the right thing and keep her promise to let Medicare negotiate lower drug prices,” the ad says. “Tell Representative Rice to vote yes on the Build Back Better Act.”
Below is a digital ad also running in the district:
“Nine out of 10 New Yorkers in Rep. Rice’s district support allowing Medicare to negotiate lower drug prices, and 8 out of 10 think drug prices are unreasonable,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It is imperative that Rep. Rice seize this moment and deliver on promises to allow Medicare to negotiate lower drug prices for Americans — instead of supporting a weak and ineffective substitute masquerading as negotiation and designed to protect Big Pharma.”
P4ADNow also launched ads today urging Reps. Lou Correa (CA-46), Scott Peters (CA-52), Stephanie Murphy (FL-07), and Josh Gottheimer (NJ-05) to pass strong Medicare negotiation legislation in the Build Back Better Act. These ads come on the heels of P4ADNow’s Arizona ad launch and are running simultaneously with two nationalads that combat Big Pharma’s lies and scare tactics. These ads are part of a seven-figure campaign that includes digital ads running across a variety of websites and news outlets and congressional outreach, where patient advocates are contacting their members of Congress to demand passage of legislation to allow Medicare to negotiate. P4ADNow’s recent ads can be found here.
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that includes legislation to let Medicare negotiate and has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, which recently advanced out of the Ways and Means Committee.
| ### |
FLORIDA — Patients For Affordable Drugs Now launched a new ad today urging Stephanie Murphy (FL-07) to vote for passage of strong Medicare negotiation legislation in the Build Back Better Act. The campaign includes TV and digital ads featuring patient advocate Kris Garcia, who lives with multiple bleeding disorders including hemophilia. It also includes grassroots advocacy, in which patients will write and call their members of Congress directly asking them to pass the Build Back Better Act, including legislation to lower drug prices for patients.
“Each infusion of medicine that I need to live costs nearly $40,000. But without it, a minor accident can become a medical crisis for me and a financial crisis for my family,” Kris, a father of three based in Denver, explains in the ad. “For millions of Americans like me, this isn’t about politics — this is about life and death.”
Rep. Murphy (FL-07) voted for a drug pricing measure to allow Medicare to negotiate lower drug prices in 2019 but voted against including identical legislation in the Build Back Better Act last month. She also joined a rival drug pricing bill that fails to empower negotiation in Medicare Part D, which accounts for 83 percent of Medicare drug spending, excludes most Part B drugs from negotiation, and has a much higher out-of-pocket cap.
Watch the FL-07 ad here.
“Stephanie Murphy has the chance to fight for Floridians by letting Medicare negotiate lower drug prices,” the ad says. “Tell Representative Murphy to stand with patients and vote yes on the Build Back Better Act.”
Below is a digital ad also running in the district:
“90 percent of Floridians in Rep. Murphy’s district support allowing Medicare to negotiate lower drug prices, and 78 percent think drug prices are unreasonable,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It is imperative that Rep. Murphy seize this moment and deliver on promises to allow Medicare to negotiate lower drug prices for Americans — instead of supporting a weak and ineffective substitute masquerading as negotiation and designed to protect Big Pharma.”
P4ADNow also launched ads today urging Reps. Lou Correa (CA-46), Scott Peters (CA-52), Josh Gottheimer (NJ-05), and Kathleen Rice (NY-04) to pass strong Medicare negotiation legislation in the Build Back Better Act. These ads come on the heels of P4ADNow’s Arizona ad launch and are running simultaneously with two nationalads that combat Big Pharma’s lies and scare tactics. These ads are part of a seven-figure campaign that includes digital ads running across a variety of websites and news outlets and congressional outreach, where patient advocates are contacting their members of Congress to demand passage of legislation to allow Medicare to negotiate. P4ADNow’s recent ads can be found here.
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that includes legislation to let Medicare negotiate and has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, which recently advanced out of the Ways and Means Committee.
| ### |
MAINE — Patients For Affordable Drugs Now launched a new ad today in Maine’s second congressional district thanking Rep. Jared Golden for fighting to let Medicare negotiate drug prices and asking him to get the job done by voting for the Build Back Better Act. The campaign includes TV and digital ads featuring patient advocate Kris Garcia, who lives with multiple bleeding disorders including hemophilia. It also includes grassroots advocacy, in which patients will write and thank Rep. Golden for his support of Medicare negotiation and ask him to pass the Build Back Better Act, including legislation to lower drug prices for patients.
“Each infusion of medicine that I need to live costs nearly $40,000. But without it, a minor accident can become a medical crisis for me and a financial crisis for my family,” Kris, a father of three based in Denver, explains in the ad. “For millions of Americans like me, this isn’t about politics — this is about life and death.”
Rep. Golden (ME-02) is a champion for allowing Medicare to negotiate lower drug prices. He campaigned on the issue and went on to vote for H.R. 3, a drug pricing measure that would allow Medicare negotiation, in 2019. Since then, he has continued to push for strong drug pricing legislation in an op-ed calling for the reform and a letter calling for inclusion of negotiation in the reconciliation package. Rep. Golden will have the opportunity to vote for passage of the current drug pricing reform legislation in the full package when it heads to the floor.
Watch the ME-02 ad here.
“Jared Golden is fighting to let Medicare negotiate lower drug prices,” the adsays. “Tell Representative Golden, ‘thank you,’ and we’re counting on him to lower drug prices by voting yes for the Build Back Better Act.”
Below is a digital ad also running in the district:
“Rep. Golden has been a real champion for patients from day one. We want him to hear loud and clear: Thank you. A vote for the Build Back Better Act is a vote for patients and lower drug prices, and we have his back,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “Medicare negotiation is the most popular part of the president’s Build Back Better Act, and 94 percent of Mainers in Rep. Golden’s district support the policy, which would lower drug prices. It’s time to get it done. ”
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that includes legislation to let Medicare negotiate and has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, which recently advanced out of the Ways and Means Committee.
| ### |
WASHINGTON, D.C. — Patients For Affordable Drugs Now launched a six-figure ad campaign today across five key House districts — Lou Correa (CA-46), Scott Peters (CA-52), Josh Gottheimer (NJ-05), Stephanie Murphy (FL-07), and Kathleen Rice (NY-04) — urging the passage of strong Medicare negotiation legislation in the Build Back Better Act. The campaign includes TV and digital ads featuring patient advocate Kris Garcia, who lives with multiple bleeding disorders including hemophilia. It also includes grassroots advocacy, in which patients will write and call their members of Congress directly asking them to pass the Build Back Better Act, including legislation to lower drug prices for patients.
“Each infusion of medicine that I need to live costs nearly $40,000. But without it, a minor accident can become a medical crisis for me and a financial crisis for my family,” Kris, a father of three based in Denver, explains in the ads. “For millions of Americans like me, this isn’t about politics — this is about life and death.”
All five members voted for H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, in 2019. This year, however, they introduced a rival drug pricing bill that fails to empower negotiation in Medicare Part D, which accounts for 83 percent of Medicare drug spending, excludes most expensive Part B drugs from negotiation, and has a much higher out-of-pocket cap.
Three of the representatives, Peters (CA-52), Murphy (FL-07), and Rice (NY-04), voted against inclusion of identical legislation in committee votes on the Build Back Better Act last month.
Watch the CA-52 ad here.
Watch the FL-07 ad here.
Watch the NY-04 ad here.
Reps. Gottheimer (NJ-05) and Correa (CA-46) have not yet had the opportunity to vote on the legislation this year, but both signed a letter voicing concerns about partisan drug pricing reforms in May. Rep. Gottheimer has criticized the Democrats’ reform efforts and defended the drug industry, and Rep. Correa enjoys a close relationship with pharma-allied groups opposed to negotiation.
Watch the NJ-05 ad here.
Watch the CA-46 ad here.
“These members of Congress have a clear choice when they vote for the reconciliation package: Stand with patients for real reform that will lower drug prices, or stand with Big Pharma to keep drug prices high,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It is imperative that Reps. Correa, Peters, Gottheimer, Murphy, and Rice seize this moment and deliver on promises to allow Medicare to negotiate lower drug prices for Americans — instead of supporting a weak and ineffective substitute masquerading as negotiation and designed to protect Big Pharma.”
P4ADNow also launched an ad today in Maine’s second congressional district thanking Rep. Jared Golden for fighting to let Medicare negotiate drug prices and asking him to get the job done by voting for the Build Back Better Act. These ads come on the heels of P4ADNow’s Arizona ad launch and are running simultaneously with two nationalads that combat Big Pharma’s lies and scare tactics. These ads are part of a seven-figure campaign that includes digital ads running across a variety of websites and news outlets and congressional outreach, where patient advocates are contacting their members of Congress to demand passage of legislation to allow Medicare to negotiate. P4ADNow’s recent ads can be found here.
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that includes legislation to let Medicare negotiate and has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices, which recently advanced out of the Ways and Means Committee.
| ### |
WASHINGTON, D.C. — Patients For Affordable Drugs Now launched a six-figure Arizona ad today as part of its campaign to support legislation that would lower drug prices for Americans by allowing Medicare to negotiate. The new ad, which will run on Arizona cable and digital platforms starting today, features Phoenix patient advocate Iesha Meza, who lives with type 1 diabetes and depends on insulin to survive. In addition to the video, Arizona advocates are contacting their members of Congress to support passage of legislation to lower drug prices.
“When you have diabetes, insulin is like water — without it, you’ll die. Now imagine if water cost $300 a vial. I had to ration my insulin, and it almost killed me,” Iesha tells Congress in the ad. “Millions of Americans can’t afford the medicines they need to survive. That shouldn’t happen in our country. We need Congress to finally do something.”
Watch the full ad here.
“Arizonans are counting on their members of Congress to pass strong drug pricing reform that includes Medicare negotiation, which 9 out of 10 of Arizona voters support,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “As our ad says, ‘Patients across Arizona need Congress to let Medicare negotiate lower drug prices. The time is now.’”
Both SenatorSinema and SenatorKelly ran on a promise to lower drug prices, and Senator Kelly has sinceadvocated for passing Medicare negotiation legislation by including it in the reconciliation package.
On Capitol Hill, Senate and House leadership along with President Biden are working to craft a reconciliation package that has the support of all Democratic members of Congress. The current House version of the package includes H.R. 3, a comprehensive bill that allows Medicare to negotiate lower prices. Senate leaders are also currently drafting legislation that will allow Medicare to negotiate, which would deliver on the president’s Build Back Better plan under rules of reconciliation.
Patients For Affordable Drugs Now is also continuing to run two nationaladsthat combat Big Pharma’s lies and scare tactics. These ads are part of a seven-figure campaign that includes digital ads running across a variety of websites and news outlets and congressional outreach, where patient advocates are contacting their members of Congress to demand passage of legislation to allow Medicare to negotiate. P4ADNow’s recent ads can be found here.
| ### |
WASHINGTON, D.C. — The following statement was issued by Sarah Kaminer Bourland, the legislative director of Patients For Affordable Drugs Now, following the House Judiciary Committee’s markup of four bills that would crack down on the drug industry’s patent abuses and promote competition in the pharmaceutical market:
“Drug companies are abusing our patent system to protect their profits and extend monopolies beyond what the law intended. These anti-competitive tactics undermine innovation and force patients to pay higher prices for longer periods of time.
“While Medicare negotiation is the cornerstone of comprehensive drug pricing reform, we applaud the House Judiciary Committee for advancing these bipartisan bills that are critical to restoring balance in our system and curbing practices such as product hopping, pay-for-delay deals, frivolous citizen petitions, and patent thicketing. Patients deserve both Medicare negotiation and patent reform, and we look forward to making sure they’re passed into law this year.”
Background:
| ### |